Bone Biologics Corporatio... (BBLGW)

AI Score

Unlock

20.20

4.60 (29.49%)

At close: Feb 26, 2025, 2:30 PM

Bone Biologics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016	Q3 2016	Q2 2016	Q1 2016
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016
Net Income	-4.11M	-4.14M	-5.12M	-6.1M	-8.95M	-6.51M	-5.8M	-4.51M	-1.48M	-2.56M	-1.85M	-1.87M	-1.61M	-1.89M	-1.77M	-1.66M	-1.82M	-1.9M	-2.07M	-2.62M	-3.42M	-4.36M	-4.04M	-4.38M	-4.43M	-5.27M	-7.56M	-5.43M	-7.05M	-9.62M	-11.46M	-17.13M	-21.03M	-24.13M	-23.12M	-19.21M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	50.00	50.00	50.00	50.00	46.00	46.00	72.00	96.00	74.00	98.00	96.00	96.00	96.00	96.00	96.00	96.00	112.00	128.00	144.00	700.00	3.4K	3.93K	4.46K
Stock-Based Compensation	188.82K	159.2K	161.29K	160.52K	152.6K	143.97K	156.47K	158.55K	266.63K	204.33K	171.8K	153.05K	15.21K	64.69K	64.69K	64.69K	64.69K	18.13K	25.42K	38.97K	49.69K	70.45K	164.32K	346.57K	516.64K	-1.5M	-1.23M	-896K	-584.03K	1.93M	2.56M	3.04M	3.46M	5.81M	5.5M	4.56M
Other Working Capital	-240.03K	-693.59K	-984.85K	-800.18K	-1.88M	-2.1M	-2.13M	-1.99M	-882.66K	-746.21K	-461.69K	-985.56K	-691.43K	103.6K	-169.94K	287.73K	289.88K	145.47K	503.53K	-216.68K	-186.2K	-801.17K	-1.36M	-619.05K	-617.91K	305.61K	830.87K	1.04M	1.04M	504.17K	17.9K	-298.36K	-347.19K	451.37K	565.06K	594.69K
Other Non-Cash Items	138.68K	126.87K	-43.75K	-1.3M	-892.69K	-3.05M	-3.58M	-2.31M	-2.68M	-598.21K	332.61K	589.6K	627.59K	977.63K	991.34K	978.65K	983.08K	989.35K	389.05K	143.86K	-94.9K	-330.44K	50.31K	214.85K	380.03K	1.09M	2.15M	2.85M	3.37M	4.29M	3.51M	4.4M	4.01M	5.87M	7.16M	5.65M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-60.05K	-60.05K	-60.05K	-60.05K	42.49K	42.49K	68.95K	74.92K	37.53K	-1M	-882.71K	-716.79K	1.62M	2.76M	-758.36K	n/a	-865.83K	666.5K	4.08M	6.09M	4.79M	3.15M	3.12M
Change in Working Capital	-150.25K	-745.18K	-1.58M	-2.07M	132.92K	-78.78K	1.21M	1.91M	-168.37K	636.49K	-202.96K	-697.55K	-320.49K	-318.4K	-196.82K	260.85K	399.68K	253.19K	611.25K	-108.97K	143.78K	294.46K	-265.95K	488.67K	145.54K	370.33K	895.59K	1.09M	938.74K	597.58K	111.31K	-204.95K	144.48K	583.71K	697.39K	299.7K
Operating Cash Flow	-4.12M	-4.79M	-6.77M	-9.51M	-9.56M	-9.49M	-7.33M	-4.06M	-3.57M	-1.8M	-1.69M	-1.96M	-1.23M	-1.17M	-961.88K	-405.04K	-426.93K	-598.93K	-1M	-2.47M	-3.25M	-4.29M	-5.1M	-4.21M	-4.1M	-3.7M	-2.98M	-3.14M	-3.33M	-3.67M	-4.61M	-5.81M	-7.33M	-7.07M	-6.61M	-5.58M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-504	-504	-504	-504	-11.4K	-11.4K	-11.4K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	47K	47K	47K
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-9.62K	-9.62K	-9.62K
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-504	-504	-504	-504	25.98K	25.98K	25.98K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	276.71K	845.96K	1.05M	1.17M	966.32K	473.77K	402.79K	399.56K	824.87K	1.75M	2.32M	2.2M	1.7M	1.3M	600K	600K	1.3M	700K	2.7M	3.9M	3.2M	3.2M	3.08M	1.88M	1.88M	3.88M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	1.81M	1.81M	299.00	n/a	n/a	4.43M	4.43M	4.43M	4.43M	6.86M	6.86M	6.86M	6.86M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.27M	3.27M	3.27M	3.27M	700K	700K	700K	700K	n/a	n/a	1.25M	4.64M	4.64M	4.64M
Financial Cash Flow	4.42M	3.9M	2.1M	6.55M	5.04M	8.88M	8.88M	4.43M	4.43M	6.86M	7.14M	7.7M	7.9M	1.17M	966.32K	473.77K	402.79K	399.56K	824.87K	1.75M	2.32M	1.23M	4M	3.6M	3.4M	4.37M	2.5M	1.9M	3.4M	4.6M	3.2M	3.2M	6.83M	9.02M	9.02M	11.02M
Net Cash Flow	298.56K	-886.16K	-4.68M	-2.96M	-4.51M	-606.66K	1.55M	373.73K	862.95K	5.06M	5.45M	5.74M	6.68M	25.06K	28.58K	92.88K	n/a	-199.37K	-176.37K	-723.98K	-931.23K	-2.09M	-128.19K	355K	265.1K	672.14K	-478.45K	-1.24M	69.9K	933.75K	-1.41M	-2.61M	-494.73K	-1.44M	-972.24K	2.05M
Free Cash Flow	-4.12M	-4.79M	-6.77M	-9.51M	-9.56M	-9.49M	-7.33M	-4.06M	-3.57M	-1.8M	-1.69M	-1.96M	-1.23M	-1.17M	-961.88K	-405.04K	-426.93K	-598.93K	-1M	-2.47M	-3.25M	-4.29M	-5.1M	-4.21M	-4.1M	-3.7M	-2.98M	-3.14M	-3.33M	-3.67M	-4.61M	-5.81M	-7.33M	-7.08M	-6.62M	-5.59M